PL316382A1 - Novel derivatives of piperidine - Google Patents
Novel derivatives of piperidineInfo
- Publication number
- PL316382A1 PL316382A1 PL95316382A PL31638295A PL316382A1 PL 316382 A1 PL316382 A1 PL 316382A1 PL 95316382 A PL95316382 A PL 95316382A PL 31638295 A PL31638295 A PL 31638295A PL 316382 A1 PL316382 A1 PL 316382A1
- Authority
- PL
- Poland
- Prior art keywords
- piperidine
- novel derivatives
- derivatives
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4410822A DE4410822A1 (en) | 1994-03-24 | 1994-03-24 | New piperidine derivatives |
PCT/DE1995/000442 WO1995025721A1 (en) | 1994-03-24 | 1995-03-23 | New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
PL316382A1 true PL316382A1 (en) | 1997-01-06 |
Family
ID=6514110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL95316382A PL316382A1 (en) | 1994-03-24 | 1995-03-23 | Novel derivatives of piperidine |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0751936A1 (en) |
JP (1) | JPH09510460A (en) |
KR (1) | KR970701695A (en) |
CN (1) | CN1145618A (en) |
AU (1) | AU2212595A (en) |
CA (1) | CA2186010A1 (en) |
CZ (1) | CZ277096A3 (en) |
DE (1) | DE4410822A1 (en) |
FI (1) | FI963786A (en) |
HU (1) | HUT75653A (en) |
IL (1) | IL113103A0 (en) |
NO (1) | NO963984D0 (en) |
PL (1) | PL316382A1 (en) |
SK (1) | SK120196A3 (en) |
WO (1) | WO1995025721A1 (en) |
ZA (1) | ZA952431B (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
ZA9610736B (en) * | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
DE69712325T2 (en) * | 1996-03-08 | 2002-11-28 | Hoffmann La Roche | USE OF 4-PHENYL-3,6-DIHYDRO-2H-PYRIDYL DERIVATIVES AS AN NMDA RECEPTOR SUBTYPE BLOCKER |
US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
IL128718A0 (en) | 1996-09-27 | 2000-01-31 | Guildford Pharmaceuticals Inc | Naaldase compositions |
US6242450B1 (en) * | 1998-07-27 | 2001-06-05 | Eli Lilly And Company | 5-HT1F antagonists |
CA2338745A1 (en) * | 1998-07-31 | 2000-02-10 | Hamideh Zarrinmayeh | Heterocyclyl sulphonamide derivatives |
CA2372715A1 (en) * | 1999-05-13 | 2001-04-12 | Shionogi & Co., Ltd. | Preventive or therapeutic drugs for diabetes |
TWI254043B (en) | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
DE60104923T2 (en) | 2000-03-22 | 2005-08-25 | F. Hoffmann-La Roche Ag | Piperidine and pirazine compounds for use in the treatment of Alzheimer's disease |
PE20020291A1 (en) | 2000-08-21 | 2002-04-17 | Hoffmann La Roche | PRO-DRUGS FOR NMDA RECEIVER LINKS |
US6770659B2 (en) * | 2002-08-26 | 2004-08-03 | Sk Corporation | Benzoyl piperidine compounds |
GB0224084D0 (en) | 2002-10-16 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
WO2018236745A1 (en) | 2017-06-20 | 2018-12-27 | Carnot, Llc | Compositions and methods for increasing efficiency of cardiac metabolism |
CN110437136A (en) * | 2019-07-30 | 2019-11-12 | 东南大学 | 1- virtue oxygen ethyl piperidine -4- base methanone derivatives and its preparation method and application |
US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3576810A (en) * | 1968-06-20 | 1971-04-27 | Robins Co Inc A H | 1-substituted-3-(-4)-aroylpiperidines |
DE2827566A1 (en) * | 1978-06-23 | 1980-01-10 | Boehringer Mannheim Gmbh | 1,2-DIHYDRO-CHINOLIN-2-ON DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
WO1982003861A1 (en) * | 1981-05-08 | 1982-11-11 | Tominaga Michiaki | Aniline derivatives,process for their preparation,and cardiotonics |
PH19166A (en) * | 1982-09-04 | 1986-01-16 | Pfizer | Dihydropyridined,pharmaceutical compositions and method of use |
FR2534580A1 (en) * | 1982-10-13 | 1984-04-20 | Synthelabo | PHENYL-1 PIPERIDINO-2 PROPANOL DERIVATIVES, THEIR PREPARATION, AND MEDICINES THAT CONTAIN THEM |
DK623586A (en) * | 1985-12-27 | 1987-06-28 | Eisai Co Ltd | PIPERIDE INGREDIENTS OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS |
US4868181A (en) * | 1986-08-04 | 1989-09-19 | E. I. Du Pont De Nemours And Company | 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity |
KR910006138B1 (en) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | Cyclic amine derivatives |
DE3888727T2 (en) * | 1987-06-02 | 1994-09-01 | Ajinomoto Kk | Use of ethylamine derivatives as antihypertensive agents. |
DE3852551T2 (en) * | 1987-12-11 | 1995-05-18 | Mitsui Petrochemical Ind | AMINES AND THEIR USE. |
SU1731048A3 (en) * | 1988-05-27 | 1992-04-30 | Эйсай Ко., Лтд (Фирма) | Process for preparing piperidine derivatives of pharmacolocically acceptable salts thereof |
FR2632641B1 (en) * | 1988-06-13 | 1990-10-12 | Irceba | ((ARYL-4-PIPERAZINYL-1) -2 ETHOXY) -3 P-CYMENE, ORTHO DERIVATIVES, META, PARA MONOSUBSTITUTED OR DISUBSTITUTED ON THE PHENYL CORE OF THIS PRODUCT, THE PROCESS FOR THE PREPARATION OF SUCH DERIVATIVES, AND THE MEDICINAL PRODUCTS AS ACTIVE PRINCIPLE |
US5153198A (en) * | 1989-03-15 | 1992-10-06 | Santen Pharmaceutical Co., Ltd. | Agent for treatment of disorders of the cerebro-neural transmission system |
US5116846A (en) * | 1990-03-28 | 1992-05-26 | Du Pont Merck Pharmaceutical Company | N-aralkyl piperidine derivatives as psychotropic drugs |
FR2681319B1 (en) * | 1991-09-12 | 1995-02-17 | Synthelabo | 1- (PHENOXYALKYL) PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION. |
ES2060547B1 (en) * | 1992-06-04 | 1995-06-16 | Ferrer Int | IMPROVEMENTS IN THE PURPOSE OF THE INVENTION PATENT N / 9201158 THAT REFERS TO "PROCEDURE FOR OBTAINING NEW DERIVATIVES OF 4-BENCILPIPERIDINE". |
FR2705343B1 (en) * | 1993-05-17 | 1995-07-21 | Fournier Ind & Sante | Beta, beta-dimethyl-4-piperidineethanamine derivatives, process for their preparation and their use in therapy. |
-
1994
- 1994-03-24 DE DE4410822A patent/DE4410822A1/en not_active Withdrawn
-
1995
- 1995-03-23 WO PCT/DE1995/000442 patent/WO1995025721A1/en not_active Application Discontinuation
- 1995-03-23 SK SK1201-96A patent/SK120196A3/en unknown
- 1995-03-23 KR KR1019960705269A patent/KR970701695A/en not_active Application Discontinuation
- 1995-03-23 EP EP95915116A patent/EP0751936A1/en not_active Withdrawn
- 1995-03-23 IL IL11310395A patent/IL113103A0/en unknown
- 1995-03-23 AU AU22125/95A patent/AU2212595A/en not_active Abandoned
- 1995-03-23 CN CN95192230A patent/CN1145618A/en active Pending
- 1995-03-23 CZ CZ962770A patent/CZ277096A3/en unknown
- 1995-03-23 JP JP7524306A patent/JPH09510460A/en active Pending
- 1995-03-23 CA CA002186010A patent/CA2186010A1/en not_active Abandoned
- 1995-03-23 PL PL95316382A patent/PL316382A1/en unknown
- 1995-03-23 HU HU9602607A patent/HUT75653A/en unknown
- 1995-03-25 ZA ZA952431A patent/ZA952431B/en unknown
-
1996
- 1996-09-23 FI FI963786A patent/FI963786A/en not_active Application Discontinuation
- 1996-09-23 NO NO963984A patent/NO963984D0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL113103A0 (en) | 1995-06-29 |
EP0751936A1 (en) | 1997-01-08 |
NO963984L (en) | 1996-09-23 |
ZA952431B (en) | 1995-12-19 |
WO1995025721A1 (en) | 1995-09-28 |
KR970701695A (en) | 1997-04-12 |
CZ277096A3 (en) | 1997-01-15 |
NO963984D0 (en) | 1996-09-23 |
HUT75653A (en) | 1997-05-28 |
DE4410822A1 (en) | 1995-09-28 |
MX9604201A (en) | 1997-12-31 |
FI963786A0 (en) | 1996-09-23 |
AU2212595A (en) | 1995-10-09 |
CA2186010A1 (en) | 1995-09-28 |
FI963786A (en) | 1996-09-23 |
JPH09510460A (en) | 1997-10-21 |
CN1145618A (en) | 1997-03-19 |
SK120196A3 (en) | 1997-10-08 |
HU9602607D0 (en) | 1996-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL311736A1 (en) | Derivatives of 1h-imidazoles | |
ZA962200B (en) | Piperidine derivatives | |
HRP940575B1 (en) | Piperidine derivatives | |
ZA962817B (en) | Novel substituted piperazine derivatives | |
PL327998A1 (en) | Novel derivatives of 19-nor-pregnene | |
PL322277A1 (en) | Derivatives of pyrazol-4-ylobenzoyl | |
PL310443A1 (en) | Derivatives of pyrolo-pyridine | |
PL329875A1 (en) | Derivatives of carbolin | |
PL329195A1 (en) | Derivatives of 6-phenylpyridol-2-amine | |
AU3351393A (en) | Piperidine derivatives | |
PL316382A1 (en) | Novel derivatives of piperidine | |
PL306127A1 (en) | Derivatives of epi-epibathydine | |
PL324451A1 (en) | Derivatives of diphenylmethylenepiperidine | |
GB2295614B (en) | Novel 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinylbenzimidazole derivatives | |
ZA955753B (en) | Heterocyclic derivatives of azolones | |
PL312692A1 (en) | New derivatives of dialkoxy-pyridinol-benzimidazole | |
PL325687A1 (en) | Derivatives of phenyloxymethyl piperidine | |
IL118161A0 (en) | Novel 4-diphenylmethyl piperidine derivatives | |
ZA955438B (en) | Polyalkylpiperidine compounds | |
ZA95694B (en) | Novel derivatives of tetramethylcyclopropane | |
PL333323A1 (en) | Derivatives of piperidine | |
PL317236A1 (en) | Derivatives of naphtoquinone | |
ZA972329B (en) | Piperidine derivatives | |
PL325816A1 (en) | Novel derivatives of naphtylpiperazine | |
PL302380A1 (en) | Novel derivative of pyrimidobenzodiazepin |